Business Wire

Huber Engineered Materials Appoints Dan Krawczyk as New President

Del

Huber Engineered Materials (HEM), a leading global producer of specialty performance ingredients for industrial and consumer products and a division of the J.M. Huber Corporation (Huber), announces that Dan Krawczyk has been appointed HEM President, effective Nov. 1, 2017. Krawczyk remains a member of the HEM Board of Directors and Huber Management Council.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171114006056/en/

HEM's Dan Krawczyk (Photo: Business Wire)

HEM's Dan Krawczyk (Photo: Business Wire)

Before becoming the President of HEM, Krawczyk served as Huber’s Executive Vice President (EVP) of Strategy & Corporate Development since 2013. He brings more than 20 years of experience in industrial and consumer products, including expertise in financial management, strategy, corporate development, marketing and operations to his new leadership role. A native of the Detroit area, Krawczyk earned an MBA as well as an MS and BS in Electrical Engineering from the University of Michigan.

Prior to joining Huber, Krawczyk was EVP and Chief Financial Officer of Gibson Guitar Corporation. He also was Global Vice President of Business Development and Strategic Marketing for Belden and has held financial and operational leadership roles at DTE Energy, Delphi Automotive and Ford Motor Company.

Looking ahead, Krawczyk plans to lead HEM into a new era of growth and change in order to successfully position the company for future generations of shareholders and employees.

“Building on a strong track record of focused market leadership, superior customer service and operational excellence, HEM has a unique opportunity today to leverage its manufacturing and applications expertise in order to pursue growth in its core businesses and expand across a range of premium functional ingredient business segments,” Krawczyk said. “We look forward to creating long-term sustainable value for all the HEM stakeholders.”

Krawczyk’s leadership was instrumental in Huber’s largest acquisition in over 10 years, the 2016 purchase of the Martinswerk business from Albemarle Corporation to become part of HEM’s already successful Fire Retardant Additives (FRA) business unit and create a global leading non-halogen flame retardants business. This move marked the latest in a series of investments in FRA, including the acquisition of the Kemgard® smoke suppressant product line from Sherwin-Williams in 2010 and purchase of the Almatis specialty hydrates business in 2012. In addition, Krawczyk led Huber’s $630 million sale of HEM’s Silica business unit to Evonik Industries AG in 2017.

About Huber Engineered Materials (www.hubermaterials.com)

Huber Engineered Materials, headquartered in Atlanta, Georgia (US), is a global business focused on engineered specialty ingredients that enhance the performance, appeal and processing of a broad range of products used in industrial and consumer-based applications. With an expertise in inorganic materials, it has a portfolio of high value products: alumina trihydrate, magnesium hydroxide, molybdate compounds, specialty aluminas and oxides, organic matting agents, barium sulfate and industrial, food and USP grade calcium carbonate.

About J.M. Huber Corporation (www.huber.com)

J.M. Huber Corporation, headquartered in Edison, New Jersey (US), operates a portfolio of companies with a focus on its core engineered materials businesses. Founded in 1883, Huber is one of the largest family-owned companies in the US. The diversified, multinational company creates products that are used in a broad range of consumer and industrial applications, including personal care, food, beverage, pharmaceuticals and building materials.

Contact information

Huber Engineered Materials
Keith Sorrell, 678-247-2730
keith.sorrell@huber.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

AURAK Gains SACSCOC Accreditation15.12.2018 10:49Pressemelding

The Southern Association of Colleges and Schools Commission on Colleges (SACSCOC) officially announced the accreditation of the American University of Ras Al Khaimah (AURAK) at its 2018 Annual Meeting which was held in New Orleans, Louisiana, in the United States of America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181215005017/en/ AURAK delegation during the SACSCOC conference in New Orleans” (Photo: AETOSWire) SACSCOC, the regional body for the accreditation of degree-granting higher education institutions in the Southern United States, has a membership of more than 800 institutions in the Southern states and other international sites approved by SACSCOC that award associate, baccalaureate, master’s, and/or doctoral degrees. SACSCOC also awards accreditation to other international institutions of higher education that satisfy all its requirements and demonstrate compliance with its accreditation standards. AURAK now

Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 17:41Pressemelding

Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut

Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 17:00Pressemelding

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl

Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 15:42Pressemelding

Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00

Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth14.12.2018 14:00Pressemelding

Residence- and citizenship-by-investment programs have firmly established themselves over the past few years as the new frontier in terms of freedom, flexibility, and future-readiness, both for the countries issuing these programs and for the individual investors participating in them. The societal and economic value these programs generate is undisputed. The investment migration industry as a whole is currently grossing roughly USD 18 billion per year, with an expectation that it will hit the USD 20 billion mark very soon. Foreign direct investment (FDI) is now considered the lifeblood of economic growth for many developing and recovering smaller countries around the world. As such, the number of investment migration programs has been increasing rapidly, from just a handful of programs in the 1980s and 1990s to over 100 countries that now have investment migration provisions in their laws. There are more than 60 active programs today, with Moldova and Montenegro — both fast-growing Eu

Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 09:07Pressemelding

Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha